College welcomes Dr. Gayle A. Brazeau to this year's EdiPhy
On August 12, the College of Pharmacy welcomed Gayle Brazeau, PhD, as a guest speaker at this year's fourth annual EdiPhy.
Buckeye BioLaunch referenced in Ohio Tech News: "Ohio State launches AI-enabled biotech initiative to speed drug discovery"
Ohio Tech News
Dr. E. Michael Murphy '18 referenced in TheStreet: "Pharmacy giant closes more stores across U.S. in 2026"
By Fernanda Tronco in TheStreet
Journal of Interprofessional Education & Practice: "Medical students reflections on interprofessional collaboration: A model for integrating IPE in clinical rotations"
Elizabeth W. Barnhardt, Stella B. Ogake, Allison Macerollo, Cynthia V. Dougherty, Elizabeth Trolli, Andrea L. Pfeifle and Alexa S. Valentino.
The American Journal of Managed Care: "Potentially Inappropriate Medication Use Following Hospital Discharge Among Medicare Beneficiaries"
Eli Wei Raver, PharmD, Jeah Jung, PhD, Macarius M. Donneyong, PhD, Tanya R. Gure, MD, Jeffrey Wing, PhD, MPH and Wendy Y. Xu, PhD.
Dr. James McAuley approved for emeritus status
On June 4, The Ohio State University Board of Trustees approved the request of James McAuley, RPh, PhD, FAPhA, to receive emeritus status.
Students and faculty provide services to seniors at Ohio State Fair
College of Pharmacy faculty and students provided services to attendees of the Healthy Aging Expo at the Ohio State Fair on August 4.
Healthcare: "Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis"
Mohammad T. Alashqar,Yazan K. Barqawi and Milap C. Nahata
Pharmacy Buckeyes immersed in genomics at the 2026 IntellxxDNA Annual Conference
On July 24, clinicians, educators and students from around the world gathered in Austin, Texas, for the 2026 IntellxxDNA Annual Conference, an event dedicated to advancing the understanding and application of genomics.
Dr. Razi Kebriaei receives a $3.7 million research award from the National Institutes of Health
Razi Kebriaei, PhD, assistant professor in the Division of Pharmaceutics and Pharmacology, has secured a $3.7 million NIH award to uncover the mechanisms behind the cefazolin inoculum effect (CzIE) and improve treatment strategies for difficult-to-treat infections.